Yahoo Web Search

Search results

1. • 

     Sanofi forecasts moderate profit growth on Dupixent demand

     Reuters via Yahoo News· 1 year ago

     (Reuters) -Sanofi forecast moderate earnings growth that undershot expectations, saying demand for...

2. • 

     Sanofi's Biggest Drug Shined. But The Rest Of Its Business Didn't.

     Investor's Business Daily· 4 months ago

     Sanofi stock undercut its 50-day line Thursday despite Dupixent outperformance as its earnings...

3. • 

     The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly

     Zacks via Yahoo Finance· 1 year ago

     For Immediate Release Chicago, IL – March 27, 2023 – Zacks.com announces the list of stocks featured...

4. • 

     Stock-Split Watch: Could These 2 Market-Beaters Be Next?

     Motley Fool via Yahoo Finance· 4 months ago

     For moves that don't improve the underlying strength of a company's business, stock splits garner a...

5. • 

     State board targets six prescription drugs to review for affordability for Marylanders

     Maryland Matters via Yahoo News· 2 weeks ago

     The board will seek public comments, additional information and data over the next 60 days to...

6. • 

     2 Smart Growth Stocks to Buy Hand Over Fist in 2024

     Motley Fool via Yahoo Finance· 4 months ago

     The stock market has given investors plenty to talk about over the last few years, and those who have stayed in it through the ups and downs have dealt...

7. • 

     Dow Jones, Financial Stocks Climb Off Lows Despite Economic Jitters; Baidu, ELF Beauty Show Strength

     Investor's Business Daily· 1 year ago

     After two straight bearish reversals off highs, sellers knocked the Dow Jones Industrial Average and...

8. • 

     2 Top Healthcare Stocks Defying the Bear Market

     Motley Fool· 1 year ago

     Among them are HCA Healthcare (NYSE: HCA) and Regeneron (NASDAQ: REGN). With recession fears alive and well, HCA Healthcare might be an excellent stock...

9. • 

     This Stock Just Dropped By 15%: Is It a Buy?

     Motley Fool· 7 months ago

     This is when corporations often take the opportunity to announce business developments which could change their prospects -- and that's exactly what...

10. • Board trying to lower drug costs urges Marylanders to help ‘fill in’ info gaps

      Maryland Matters via Yahoo News· 1 month ago

      The Prescription Drug Affordability Board is seeking feedback from patients, physicians and manufactures to provide context and first-hand experience about trying to afford medications for certain ...